Should Cancer Trial Eligibility Become More Inclusive?July 10, 2024Patient & Survivor CareDLBCLOpioid Resource CenterPediatricsAggressive LymphomasALLAML
Feds May End Hospital System’s Noncompete Contract for Part-Time DocsJuly 8, 2024Business of Medicine
Time Warp: Fax Machines Still Common in Oncology Practice. Why?July 3, 2024DLBCLGene TherapyMixed TopicsPediatricsAggressive LymphomasALLAML
Cancer Drug Shortages Continue in the US, Survey FindsJuly 3, 2024Aggressive LymphomasALLAMLB Cell LymphomaCLLCMLHodgkin Lymphoma
FDA Proposes that Interchangeability Status for Biosimilars Doesn’t Need Switching StudiesJune 28, 2024Business of MedicineMixed Topics
Oncology Mergers Are on the Rise. How Can Independent Practices Survive?June 25, 2024DLBCLMixed TopicsPediatricsBusiness of MedicineAggressive LymphomasALLAML
US Hospitals Prone to Cyberattacks Like One That Impacted Patient Care at Ascension, Experts SayJune 21, 2024Business of Medicine
Doctors Endorsing Products on X May Not Disclose Company TiesJune 19, 2024DLBCLGene TherapyMixed TopicsBusiness of MedicineAggressive LymphomasALLAML
AMA Wrestles With AI But Acts on Prior Authorization, Other ConcernsJune 14, 2024Business of Medicine
The ASCO Annual Meeting Starts This WeekMay 30, 2024Mixed TopicsDLBCLPatient & Survivor CareAggressive LymphomasALLAMLCML
Does More Systemic Treatment for Advanced Cancer Improve Survival?May 22, 2024Patient & Survivor CareDLBCLMixed TopicsBusiness of MedicineAggressive LymphomasALLAML
